Letter to the Editor

Issue: Ahead-of-Print Publication Date: 2026-03-17
The effective use of platelet-rich plasma (PRP) in treating a severe traumatic knee injury in a child with hemophilia A: PRP in the treatment of severe injury in hemophilia child

Samantha Pasca, Federica Fati, Clara Revetria, Stella Poda, Sonia Secchi
Issue: Vol. 24 No. 2 (2026): Blood Transfusion 2-2026 (March-April) Publication Date: 2025-11-27
No bleeding during a dialysis catheter insertion in a patient with INR 3.2 due to acute liver dysfunction: No bleeding during dialysis catheter insertion with INR 3.2

Piotr Czempik, Tomasz Jaworski
Issue: Vol. 24 No. 2 (2026): Blood Transfusion 2-2026 (March-April) Publication Date: 2025-11-20
Molecularly confirmed para-Bombay (Ah) secretor phenotype with FUT1 c.328G>A and FUT2 c.357C>T mutations: first case report from India: Para-Bombay Ah secretor phenotype from India

Thamizhsurabi Arivazhagan, Tejaswi Chada, Srinivasa Rao Chunchu, Monali Lokhande, Rati Devendra
Issue: Vol. 23 No. 6 (2025): Blood Transfusion 6-2025 (November-December) Publication Date: 2025-04-15
Gender difference among blood donors: should laboratory ranges be changed? Gender difference in laboratory ranges

Samantha Pasca, Sonia Secchi, Luca Postal, Paola Boccagni
Issue: Vol. 23 No. 2 (2025): Blood Transfusion 2-2025 (March-April) Publication Date: 2025-01-21
Cryoprecipitate should not be the essential medicine recommended by the WHO to treat haemophilia: Factor VIII concentrate rather than cryoprecipitate for Haemophilia

Mike Makris, Cedric Hermans
Issue: Vol. 23 No. 2 (2025): Blood Transfusion 2-2025 (March-April) Publication Date: 2025-01-21
Recommending defunct therapies is a safety risk for hemophilia: Therapies and safety risks in haemophilia

Glenn Pierce, Brian O'Mahony, Radoslaw Kaczmarek, Salome Mekhuzia, Mark Skinner
Issue: Vol. 23 No. 2 (2025): Blood Transfusion 2-2025 (March-April) Publication Date: 2025-01-21
Response to comments on inclusion of cryoprecipitate, pathogen-reduced on the WHO model lists of essential medicines for adults and children: a call for action: Responses to comments on Cryo-PR listing on the WHO EML

Jay Epstein, Yuyun Maryuningsih, Jean-Claude Faber, W. Martin Smid, Thierry Burnouf
Issue: Vol. 23 No. 4 (2025): Blood Transfusion 4-2025 (July-August) Publication Date: 2024-11-29
Identification of a novel ABO*O.01.01 allele with c.801G>T mutation in a Chinese A2 subtype individual: A novel ABO*O.01.01 allele with c.801G>T

Chonghe Xu, Zhongqi Zhu, Mei Zhu, Wei Xu
Issue: Vol. 23 No. 3 (2025): Blood Transfusion 3-2025 (May-June) Publication Date: 2024-11-29
Post-transplant pediatric autoimmune hemolytic anemia: donor vs donor or recipient vs self? Post-transplant pediatric AIHA

Alessandra Bernardi, Pierpaolo Berti, Elisabetta Cicchetti, Fabiola Landi, Ottavia Porzio
Issue: Vol. 22 No. 6 (2024): Blood Transfusion 6-2024 (November-December) Publication Date: 2024-07-22
Implementing Patient Blood Management in major digestive surgery: should we do more? Implementing PBM issues

Marco Catarci
Issue: Vol. 22 No. 5 (2024): Blood Transfusion 5-2024 (September-October) Publication Date: 2024-05-23
Description of the first case of c.137-8C>T GYPB mutation not associated to the GYPB(P2) allele: c.137-8C>T GYPB mutation not associated to the GYPB(P2) allele

Luca Collodel, Gianluca Gessoni, Tommaso Mancuso
Issue: Vol. 22 No. 3 (2024): Blood Transfusion 3-2024 (May-June) Publication Date: 2024-03-04
Thrombotic thrombocytopenic purpura: optimal management of plasma exchange, platelets and infection prevention: Thrombotic thrombocytopenic purpura: optimal management

Ingrid Parra-Salinas, Juan Rodríguez-García, Saioa Zalba-Marcos , José Antonio García-Erce
Issue: Vol. 22 No. 3 (2024): Blood Transfusion 3-2024 (May-June) Publication Date: 2024-03-04
Types of plasma exchange solution in the new scenario of thrombotic thrombocytopenic purpura treatment: .

Nadia Garcia Muñoz, Sandra Ortega Sanchez, Joan R Grifols
Issue: Vol. 22 No. 4 (2024): Blood Transfusion 4-2024 (July-August) Publication Date: 2023-12-19
Establishment of a case registry that collaborates with a reference laboratory for blood group immunogenetics in Korea: Blood group immunogenetics case registry and laboratory

Dong Woo Shin, Yun Ji Hong, Kyoung Un Park
Issue: Vol. 22 No. 4 (2024): Blood Transfusion 4-2024 (July-August) Publication Date: 2023-11-30
DENV outbreak in Italy: the impact on the national transfusion network: DENV outbreak in Italy: the impact on the national transfusion network

Ilaria Pati, Giulio Pisani, Flavia Riccardo, Giulietta Venturi, Vincenzo De Angelis
Issue: Vol. 22 No. 4 (2024): Blood Transfusion 4-2024 (July-August) Publication Date: 2023-11-09
A potential food-related acute allergic transfusion reaction: Food-related allergic transfusion reaction

Kelly Johnson-Arbor, Colleen Gilstad, Richard Verstraete
Issue: Vol. 22 No. 1 (2024): Blood Transfusion 1-2024 (January-February) Publication Date: 2023-10-24
Autologous transfusion requirements in bone marrow harvest: results of the ATREMA study: PBM in bone marrow harvest

Caterina Giovanna Valentini, Idanna Innocenti, Claudio Pellegrino, Gaetano Draisci, Luciana Teofili
Issue: Vol. 22 No. 1 (2024): Blood Transfusion 1-2024 (January-February) Publication Date: 2023-07-31
A novel method for antibody specificity identification using microscale direct antiglobulin test-positive red cells: Antibody identification of DAT positive red cells

Yuyu Zhang, Dong Xiang
Issue: Vol. 22 No. 1 (2024): Blood Transfusion 1-2024 (January-February) Publication Date: 2023-06-12
Significant neutropenia induced by metamizole dependent neutrophil antibodies: Metamizole and neutropenia

Brian R Curtis, Stefanie Jehle, Gregor Bein, Behnaz Bayat, Ulrich J Sachs
Issue: Vol. 21 No. 4 (2023): Blood Transfusion 4-2023 (July-August) Publication Date: 2023-04-13
Lack of information as a barrier to blood donation: results from a survey of pharma industry workers in Italy : Survey on blood donation

Massimiliano Copetti, Carmen Di Silvio, Rosanna Mangiarotti, Alessandra Vignoli, Laura Franzini
Issue: Blood Transfusion - 2 2019 (March-April) Publication Date: 2022-12-02
A case of dabigratan-related acute agranulocytosis

Ahmad Al-Khaffaf, Francesco Frattini, Cinzia Sissa, Elda Mimiola, Massimo Franchini
Issue: Blood Transfusion - 6 2022 (November-December) Publication Date: 2022-07-22
Continuous population surveillance of COVID-19 immunity can be provided by Blood Services at low cost using routine laboratory infrastructure

Stephen M. Henry, Willy A. Flegel, Christof Weinstock
Issue: Blood Transfusion - 6 2022 (November-December) Publication Date: 2022-07-22
COVID-19 vaccination, anticoagulation level and warfarin treatment

Rujittika Mungmunpuntipantip, Viroj Wiwanitkit
Issue: Blood Transfusion - 6 2022 (November-December) Publication Date: 2022-07-22
Lack of influence of SARS-CoV 2 vaccination on anticoagulation levels of patients on stable, long-term warfarin treatment

Elena Lotti, Alessandro Masi, Chiara Cappugi, Alessandra Fanelli, Lucia Mannini, Rossella Marcucci, Daniela Poli
Issue: Vol. 21 No. 4 (2023): Blood Transfusion 4-2023 (July-August) Publication Date: 2022-06-07
A novel serological RhD confirmatory test for patients with warm autoimmune haemolytic anaemia with a strong positive direct antiglobulin test: A novel RhD confirmatory test for WAIHA patients

Chunchen Yang, Jiewei Zheng, Ruiming Rong, Dong Xiang
Issue: Blood Transfusion - 3 2022 (May-June) Publication Date: 2021-09-22
Blood donor serological screening for SARS-CoV-2 as a tool to estimate the prevalence of asymptomatic infection in a low-intermediate endemic area of southern Italy after the first wave of the pandemic

Federica Calò, Alessandra Di Fraia, Antonio Russo, Antonio Di Biase, Saverio Misso, Nicola Coppola
Issue: Blood Transfusion - 2 2022 (March-April) Publication Date: 2021-03-30
Iron parenteral administration: an expert opinion on the assessment of fetal wellbeing

Antonio Ragusa, Alessandro Svelato, Matteo Bolcato
Issue: Blood Transfusion - 2 2022 (March-April) Publication Date: 2021-03-30
Organisational strategies for the safe management of intravenous iron therapy: a revolutionary tool for implementing Patient Blood Management

Matteo Bolcato, Ivo Beverina
Issue: Blood Transfusion - 2 2021 (March-April) Publication Date: 2020-12-23
Making friends out of foes: novel therapeutic approaches for haemophilia

Catriona Mactier, Cedric Hermans
Issue: Blood Transfusion - 2 2021 (March-April) Publication Date: 2020-12-22
Appropriate red cell transfusions are often avoidable through Patient Blood Management

Kevin M. Trentino, Hamish S. Mace, Michael F. Leahy, Frank M. Sanfilippo, Shannon L. Farmer, Kevin Murray
Issue: Blood Transfusion - 1 2021 (January-February) Publication Date: 2020-11-12
On the association between the ABO blood group and COVID-19 susceptibility

Davide Golinelli
Issue: Blood Transfusion - 1 2021 (January-February) Publication Date: 2020-10-09
Transfusion of a D-- phenotype patient using the rare blood donor registry of the Korean Red Cross Blood Services

Jay Ho Han, So-Yong Kwon, Dong Wook Jekarl
Issue: Blood Transfusion - 6 2020 (November-December) Publication Date: 2020-09-18
Haemophilia A/B carriers: haemorrhagic burden of disease and open issues

Samantha Pasca, Ezio Zanon
Issue: Blood Transfusion - 5 2020 (September-October) Publication Date: 2020-07-29
Prevalence and clinical features of COVID-19 in Iranian patients with congenital coagulation disorders

Mehran Karimi, Sezaneh Haghpanah, Amin Shahsavani
Issue: Blood Transfusion - 4 2020 (July-August) Publication Date: 2020-07-13
Therapeutic choices in persons with haemophilia at the time of COVID-19

Antonio Coppola, Federica Riccardi, Annarita Tagliaferri
Issue: Blood Transfusion - 4 2020 (July-August) Publication Date: 2020-07-13
Detection of anti-heparin-PF4 complex antibodies in COVID-19 patients on heparin therapy

Daniela Dragonetti, Giuseppe Guarini, Michele Pizzuti
Issue: Blood Transfusion - 3 2020 (May-June) Publication Date: 2020-05-07
Use of eye drops obtained from homologous blood source in the time of COVID-19: is there cause for ophthalmological concern?

Giuseppe Giannaccare, Marina Buzzi, Piera Versura
Issue: Blood Transfusion - 3 2020 (May-June) Publication Date: 2020-05-07
A multimodal practical approach in a Transfusion Medicine Centre to face the COVID-19 outbreak

Valentino Granero, Paola M. Manzini, Anna M. Bordiga
Issue: Blood Transfusion - 3 2020 (May-June) Publication Date: 2020-05-07
Is thromboprophylaxis with high-dose enoxaparin really necessary for COVID-19 patients? A new “prudent” randomised clinical trial

Marco Cattaneo, Nuccia Morici
Issue: Blood Transfusion - 3 2020 (May-June) Publication Date: 2020-05-07
Rebuttal to letter "Is thromboprophylaxis with high-dose enoxaparin really necessary for COVID-19 patients? A new “prudent” randomised clinical trial"

Marco Marietta, Armando Tripodi
Issue: Blood Transfusion - 1 2019 (January-February) Publication Date: 2018-11-07
Cost of Pathogen Reduction for platelets: reply to Cicchetti et al. Blood Transfus 2018; 16: 483-9

Albert Farrugia
Issue: Blood Transfusion - 1 2019 (January-February) Publication Date: 2018-04-04
On the cost-utility of methylene blue-photoinactivated plasma versus quarantine plasma in Spain

Arturo Pereira, Julio del Río-Garma, José A. García-Erce
Issue: Blood Transfusion - 1 2019 (January-February) Publication Date: 2017-12-22
Further comments on "High-titre inhibitors in previously untreated patients with severe haemophilia A receiving recombinant or plasma-derived factor VIII: a budget-impact analysis"

Andrea Messori, Flora Peyvandi, Sabrina Trippoli, Roberta Palla, Frits R. Rosendaal, Pier Mannuccio Mannucci
Issue: Blood Transfusion - 1 2019 (January-February) Publication Date: 2017-10-03
Reply to "High-titre inhibitors in previously untreated patients with severe haemophilia A receiving recombinant or plasma-derived factor VIII: a budget-impact analysis" by Messori et al.

Albert Farrugia, Megha Bansal
Issue: Blood Transfusion - 1 2018 (January - February) Publication Date: 2016-09-22
Preserved in vitro metabolic and functional characteristics of double-dose apheresis platelet concentrates photochemically treated with amotosalen and ultraviolet A light

Per Sandgren

Submit an Article

PLASTIC RECONSTRUCTIVE AND REGENERATIVE SURGERY

Letter to the Editor

The effective use of platelet-rich plasma (PRP) in treating a severe traumatic knee injury in a child with hemophilia A: PRP in the treatment of severe injury in hemophilia child

No bleeding during a dialysis catheter insertion in a patient with INR 3.2 due to acute liver dysfunction: No bleeding during dialysis catheter insertion with INR 3.2

Molecularly confirmed para-Bombay (Ah) secretor phenotype with FUT1 c.328G>A and FUT2 c.357C>T mutations: first case report from India: Para-Bombay Ah secretor phenotype from India

Gender difference among blood donors: should laboratory ranges be changed? Gender difference in laboratory ranges

Cryoprecipitate should not be the essential medicine recommended by the WHO to treat haemophilia: Factor VIII concentrate rather than cryoprecipitate for Haemophilia

Recommending defunct therapies is a safety risk for hemophilia: Therapies and safety risks in haemophilia

Response to comments on inclusion of cryoprecipitate, pathogen-reduced on the WHO model lists of essential medicines for adults and children: a call for action: Responses to comments on Cryo-PR listing on the WHO EML

Identification of a novel ABO*O.01.01 allele with c.801G>T mutation in a Chinese A2 subtype individual: A novel ABO*O.01.01 allele with c.801G>T

Post-transplant pediatric autoimmune hemolytic anemia: donor vs donor or recipient vs self? Post-transplant pediatric AIHA

Implementing Patient Blood Management in major digestive surgery: should we do more? Implementing PBM issues

Description of the first case of c.137-8C>T GYPB mutation not associated to the GYPB(P2) allele: c.137-8C>T GYPB mutation not associated to the GYPB(P2) allele

Thrombotic thrombocytopenic purpura: optimal management of plasma exchange, platelets and infection prevention: Thrombotic thrombocytopenic purpura: optimal management

Types of plasma exchange solution in the new scenario of thrombotic thrombocytopenic purpura treatment: .

Establishment of a case registry that collaborates with a reference laboratory for blood group immunogenetics in Korea: Blood group immunogenetics case registry and laboratory

DENV outbreak in Italy: the impact on the national transfusion network: DENV outbreak in Italy: the impact on the national transfusion network

A potential food-related acute allergic transfusion reaction: Food-related allergic transfusion reaction

Autologous transfusion requirements in bone marrow harvest: results of the ATREMA study: PBM in bone marrow harvest

A novel method for antibody specificity identification using microscale direct antiglobulin test-positive red cells: Antibody identification of DAT positive red cells

Significant neutropenia induced by metamizole dependent neutrophil antibodies: Metamizole and neutropenia

Lack of information as a barrier to blood donation: results from a survey of pharma industry workers in Italy : Survey on blood donation

A case of dabigratan-related acute agranulocytosis

Continuous population surveillance of COVID-19 immunity can be provided by Blood Services at low cost using routine laboratory infrastructure

COVID-19 vaccination, anticoagulation level and warfarin treatment

Lack of influence of SARS-CoV 2 vaccination on anticoagulation levels of patients on stable, long-term warfarin treatment

A novel serological RhD confirmatory test for patients with warm autoimmune haemolytic anaemia with a strong positive direct antiglobulin test: A novel RhD confirmatory test for WAIHA patients

Blood donor serological screening for SARS-CoV-2 as a tool to estimate the prevalence of asymptomatic infection in a low-intermediate endemic area of southern Italy after the first wave of the pandemic

Iron parenteral administration: an expert opinion on the assessment of fetal wellbeing

Organisational strategies for the safe management of intravenous iron therapy: a revolutionary tool for implementing Patient Blood Management

Making friends out of foes: novel therapeutic approaches for haemophilia

Appropriate red cell transfusions are often avoidable through Patient Blood Management

On the association between the ABO blood group and COVID-19 susceptibility

Transfusion of a D-- phenotype patient using the rare blood donor registry of the Korean Red Cross Blood Services

Haemophilia A/B carriers: haemorrhagic burden of disease and open issues

Prevalence and clinical features of COVID-19 in Iranian patients with congenital coagulation disorders

Therapeutic choices in persons with haemophilia at the time of COVID-19

Detection of anti-heparin-PF4 complex antibodies in COVID-19 patients on heparin therapy

Use of eye drops obtained from homologous blood source in the time of COVID-19: is there cause for ophthalmological concern?

A multimodal practical approach in a Transfusion Medicine Centre to face the COVID-19 outbreak

Is thromboprophylaxis with high-dose enoxaparin really necessary for COVID-19 patients? A new “prudent” randomised clinical trial

Rebuttal to letter "Is thromboprophylaxis with high-dose enoxaparin really necessary for COVID-19 patients? A new “prudent” randomised clinical trial"

Cost of Pathogen Reduction for platelets: reply to Cicchetti et al. Blood Transfus 2018; 16: 483-9

On the cost-utility of methylene blue-photoinactivated plasma versus quarantine plasma in Spain

Further comments on "High-titre inhibitors in previously untreated patients with severe haemophilia A receiving recombinant or plasma-derived factor VIII: a budget-impact analysis"

Reply to "High-titre inhibitors in previously untreated patients with severe haemophilia A receiving recombinant or plasma-derived factor VIII: a budget-impact analysis" by Messori et al.

Preserved in vitro metabolic and functional characteristics of double-dose apheresis platelet concentrates photochemically treated with amotosalen and ultraviolet A light

Information

Identification of a novel ABOO.01.01 allele with c.801G>T mutation in a Chinese A2 subtype individual: A novel ABOO.01.01 allele with c.801G>T